Financials data is unavailable for this security.
View more
Year on year Life Science REIT PLC grew revenues 26.97% from 15.71m to 19.94m while net income improved from a loss of 27.61m to a smaller loss of 21.71m.
| Gross margin | 69.33% |
|---|---|
| Net profit margin | -108.85% |
| Operating margin | -73.16% |
| Return on assets | -5.06% |
|---|---|
| Return on equity | -7.20% |
| Return on investment | -5.47% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Life Science REIT PLC fell by 31.27m. However, the company earned 7.62m from its operations for a Cash Flow Margin of 38.19%. In addition the company used 11.64m on investing activities and also paid 27.24m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.8107 |
|---|---|
| Tangible book value per share | 0.8107 |
More ▼
Balance sheet in GBPView more
| Current ratio | 1.45 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.3803 |
|---|---|
| Total debt/total capital | 0.2755 |
More ▼
Growth rates in GBP
Year on year, growth in dividends per share fell -50.00% while earnings per share excluding extraordinary items rose 21.38%.
| Div yield(5 year avg) | 1.74% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 21.40 |
More ▼
